Prosecution Insights
Last updated: October 27, 2026

The Texas A&M University System

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems

59 pending office actions • 45 art units • 58 examiners • 0 of 59 (0%) have an AI response strategy ready • 85 patents granted in the last 365 days

Analysis

The Texas A&M University System has 57 pending office actions in Biotechnology & Pharmaceuticals. The portfolio spans 57 distinct examiners and 45 distinct art units. The matching office-action and examiner figures show that each pending matter is associated with a separate examiner, while the lower art-unit figure reflects some technical grouping at the art-unit level.

LAMPRECHT, JOEL is the busiest examiner, with 1 pending matter. This limited concentration means that docket oversight should address many examiner relationships rather than rely on a narrow set of recurring contacts. The breadth of assignments also supports maintaining claim, disclosure, and response strategies that can be adapted across multiple biotechnology and pharmaceutical examination contexts.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

59
Total Pending OAs
42
Non-Final OAs
17
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 20 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
0
Due this week
7
Due this month
1
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 20 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 30 days (7)Due ≤ 60 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

28
Hard (47%)
23
Medium (39%)
8
Easy (14%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (3%)
§101 + other5 (8%)
§103 only18 (31%)
§102 only3 (5%)
§112 only5 (8%)
Double-patenting only3 (5%)
Double-patenting + other2 (3%)
Multi-statute (no §101)21 (36%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

33
Life Sciences
56% of docket
1
Information Tech
2% of docket
0
Communications
0% of docket
3
Semiconductors
5% of docket
20
Mechanical / Eng
34% of docket
2
Business / Other
3% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

590 h
Manual time on pending OAs
118 h
Time saved (low, 20%)
206 h
Time saved (mid, 35%)
5.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
OQUENDO, CARIB A 2 78.0% +12.2%
LAMPRECHT, JOEL 1 81.4% +16.5%
RUSHING, JR, BOBBY 1 76.5% +12.0%
GILLS, KURTIS 1 58.0% +28.8%
KHAYER, SOHANA T 1 82.1% +18.3%
SINGH, ALEXANDER A 1 77.1% +2.2%
CALAMITA, HEATHER 1 38.1% +9.6%
TOLEDO-DURAN, EDWIN J 1 70.0% +31.7%
CODRINGTON, SHANE WRENSFORD 1 75.0% +29.2%
TANNER, JOCELIN C 1 72.3% +34.7%

Hard Cases (28)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18645578 CUSTOMER NOTIFICATION SYSTEM BASED ON OUTAGE STATE OF RISK PREDICTION ULLAH, ARIF 147d overdue
18526487 METHODS OF TREATING COMPOUNDS USING VISIBLE LIGHT-ENABLED ACTIVATION OF PEROXYDISULFATE MENON, KRISHNAN S 31d overdue
18670411 METHOD FOR TREATMENT AND CONTROL OF PLANT DISEASE SWIFT, CANDICE LEE 30d overdue
17640128 USE OF ENCAPSULATED STEROLS TO MODIFY GROWTH OF CROPS, CONTROL, AGRICULTURAL PESTS AND AS NON-TOXIC PRE-EMERGENT HERBICIDES FAY, ZOHREH ALEMZADEH 22d overdue
18288289 INTRACELLULAR TARGETED NANOCARRIERS: TOWARDS CONTROLLED DRUG DELIVERY FOR NONINVASIVE NEUROREGENERATION TREATMENT SAEED, ALI S 19d overdue
18123171 OFFSHORE ANCHORING SYSTEMS AND ASSOCIATED METHODS BURGESS, MARC R 15d overdue
17772539 PROTEASE SWITCH FOR DUAL TARGETS CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY REGLAS, GILLIAN CHELSEA 4d overdue
18224207 SYSTEMS AND METHODS FOR PREPARATION OF HIGHLY REACTIVE ALKALI METAL DENDRITES FOR THE SYNTHESIS OF ORGANOLITHIUM REAGENTS BRADY, KRISTEN WEEKS 12d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19309046 NON-INVASIVE ESTIMATION OF MATERIAL PARAMETERS LAMPRECHT, JOEL —
19265643 INERT GAS ENABLED EXTREME WEAR RESISTANCE OF ELECTRIFIED MOVING COMPONENTS RUSHING, JR, BOBBY —
19197358 GAMIFIED VIRTUAL CONSTRUCTION LAB GILLS, KURTIS —
19192820 CYCLOIDAL LEGS-AUGMENTED WHEELS FOR STAIR AND OBSTACLE CLIMBING IN MOBILE ROBOTS KHAYER, SOHANA T —
19072786 SYSTEMS AND METHODS FOR BLOCKING A SURGE OF WATER TOLEDO-DURAN, EDWIN J —
19072770 SYSTEMS AND METHODS FOR BLOCKING A SURGE OF WATER OQUENDO, CARIB A —
19072749 SYSTEMS AND METHODS FOR BLOCKING A SURGE OF WATER OQUENDO, CARIB A —
19041936 SYSTEMS, DEVICES, AND METHODS FOR MOTILITY-BASED DETECTION OF BACTERIA AND EVALUATION OF SENSITIVITY TO ANTIBACTERIAL AGENT CODRINGTON, SHANE WRENSFORD —

Top Art Units

Art UnitApps
3678 3
3791 3
3798 2
1788 2
1672 2
2855 2
1663 2
1657 2
3625 2
1631 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19309046 NON-INVASIVE ESTIMATION OF MATERIAL PARAMETERS LAMPRECHT, JOEL 3798 §101§112 Non-Final OA — Pending Aug 25, 2025
19265643 INERT GAS ENABLED EXTREME WEAR RESISTANCE OF ELECTRIFIED MOVING COMPONENTS RUSHING, JR, BOBBY 3618 §102§103§112 Non-Final OA — Pending Jul 10, 2025
19197358 GAMIFIED VIRTUAL CONSTRUCTION LAB GILLS, KURTIS 3624 §101§102 Non-Final OA — Pending May 02, 2025
19192820 CYCLOIDAL LEGS-AUGMENTED WHEELS FOR STAIR AND OBSTACLE CLIMBING IN MOBILE ROBOTS KHAYER, SOHANA T 3657 §102§103 Non-Final OA — Pending Apr 29, 2025
19171265 HIGH TORQUE DENSITY ELECTRIC MACHINE WITH DIRECTLY COOLED END WINDINGS SINGH, ALEXANDER A 2834 §103 Non-Final OA — Pending Apr 06, 2025
19086700 PURPLE-FLESHED SWEETPOTATO LINES AND METHODS THEREOF CALAMITA, HEATHER 1684 §112 Non-Final OA — Pending Mar 21, 2025
19072786 SYSTEMS AND METHODS FOR BLOCKING A SURGE OF WATER TOLEDO-DURAN, EDWIN J 3678 DP Non-Final OA — Pending Mar 06, 2025
19072770 SYSTEMS AND METHODS FOR BLOCKING A SURGE OF WATER OQUENDO, CARIB A 3678 DP Non-Final OA — Pending Mar 06, 2025
19072749 SYSTEMS AND METHODS FOR BLOCKING A SURGE OF WATER OQUENDO, CARIB A 3678 DP Non-Final OA — Pending Mar 06, 2025
19041936 SYSTEMS, DEVICES, AND METHODS FOR MOTILITY-BASED DETECTION OF BACTERIA AND EVALUATION OF SENSITIVITY TO ANTIBACTERIAL AGENT CODRINGTON, SHANE WRENSFORD — §103 Non-Final OA — Pending Jan 30, 2025
19018495 BIOCOMPATIBLE BIOMEDICAL OCCLUSION DEVICE TANNER, JOCELIN C 3771 §103 Non-Final OA — Pending Jan 13, 2025
19017990 MEDICAL DEVICES COATED WITH SHAPE MEMORY POLYMER FOAMS GOLDEN, CHINESSA T 1788 §103 Non-Final OA — Pending Jan 13, 2025
19000508 ANTIBODIES FOR TREATMENT OF CORONAVIRUS DISEASE CORNELIUS, CLAIRE ADRIENNE 1672 §103§112 Non-Final OA — Pending Dec 23, 2024
18862423 SURFACE-MICROMACHINED FABRY-PÉROT SENSORS AND ARRAY CASTELLON JR, MANUEL SALVADOR 2855 §103 Non-Final OA — Pending Nov 01, 2024
18914168 MOLECULARLY IMPRINTED WEARABLE SENSOR WITH PAPER MICROFLUIDICS FOR REAL TIME SWEAT BIOMARKER ANALYSIS LOPEZ, SEVERO ANTON P 3791 §103 Non-Final OA — Pending Oct 12, 2024
18849273 NANOCOMPOSITE AND METHOD OF MAKING THE SAME FERRE, ALEXANDRE F 1788 §102§103 Non-Final OA — Pending Sep 20, 2024
18820428 Drug Eluting Shape Memory Foam RIETH, STEPHEN EDWARD 1759 §112Other Non-Final OA — Pending Aug 30, 2024
18804525 CORN ENDOTYPE-DERIVED POLYPEPTIDES CAPABLE OF METABOLIZING FUMONISIN WILLIAMS, KEITH RICHARD 1663 §102§112 Non-Final OA — Pending Aug 14, 2024
18837026 SARS-COV-2 NEUTRALIZING SYNTHETIC PROTEINS SALVOZA, M FRANCO G 1672 §102§103§112DP Non-Final OA — Pending Aug 08, 2024
18782100 LOCKED APTAMER HAIRPIN INTEGRATED HYBRIDIZATION CHAIN REACTION FOR RAPID, INSTRUMENT-FREE BIOMARKER DETECTION TURPIN, ZACHARY MARK 1682 §103§112 Non-Final OA — Pending Jul 24, 2024
18680572 SELF-SUFFICIENT LOW-COST MITIGATION MODEL TO IMPROVE RESILIENCE IN POWER UTILITY WILDFIRE RESPONSE NGUYEN, NGA X 3662 §103 Non-Final OA 76d Pending May 31, 2024
18670411 METHOD FOR TREATMENT AND CONTROL OF PLANT DISEASE SWIFT, CANDICE LEE 1657 §101§112 Non-Final OA 30d overdue Pending May 21, 2024
18668700 ELECTROCHEMICAL STORAGE INCORPORATING SIZE- AND MORPHOLOGY-CONTROLLED METASTABLE VANADIUM PENTOXIDE AS A CATHODE MATERIAL FOR ION BATTERIES DOVE, TRACY MAE 1725 §103§112 Non-Final OA — Pending May 20, 2024
18645578 CUSTOMER NOTIFICATION SYSTEM BASED ON OUTAGE STATE OF RISK PREDICTION ULLAH, ARIF 3625 §101§103 Final Rejection 147d overdue Pending Apr 25, 2024
18638104 MACHINE LEARNING METHODS AND SYSTEMS TO DETECT INTERNAL MARKERS USING ULTRASOUND IMAGING CELESTINE, NYROBI I 3798 §102§103§112 Non-Final OA 41d Pending Apr 17, 2024
18632858 SUSTAINABLE ENERGY-BASED CONTACTLESS REVERSE OSMOSIS (CRO) BY LOW ENERGY PUMP FOR SMART PORTABLE WATER FILTRATION SYSTEM SHIPMAN, KYLE HARRISON 1771 §103 Non-Final OA — Pending Apr 11, 2024
18608584 EX-SITU DEVICE FOR MEASUREMENTS OF LIQUID-CONTAINER RELATIONSHIPS MAHONEY, CHRISTOPHER E 2855 §102§103 Non-Final OA — Pending Mar 18, 2024
18591213 ABCG-TYPE SORGOLEONE TRANSPORTER FROM SORGHUM BICOLOR SPEED, DEQUANTARIUS JAVON 1663 §112 Non-Final OA 26d overdue Pending Feb 29, 2024
18437149 INTELLIGENT CONTROL FOR CELLULAR RADIO ACCESS NETWORKS MILLS, DONALD L 2462 §102 Non-Final OA — Pending Feb 08, 2024
18292542 VACCINE COMPOSITIONS COMPRISING BRUCELLA STRAINS AND METHODS THEREOF DICKENS, AMELIA NICOLE 1645 §102§103 Final Rejection 62d Pending Jan 26, 2024
18574081 MICROFLUIDIC DEVICE MIMICKING TUMOR MICROENVIRONMENT CARREON, ADRIAN JOHN 1799 §103§112 Final Rejection — Pending Dec 26, 2023
18526487 METHODS OF TREATING COMPOUNDS USING VISIBLE LIGHT-ENABLED ACTIVATION OF PEROXYDISULFATE MENON, KRISHNAN S 1777 §102§103§112 Final Rejection 31d overdue Pending Dec 01, 2023
18562374 BIODEGRADABLE MUCOADHESIVE PHARMACEUTICAL FORMULATIONS AND METHODS THEREOF MERCIER, MELISSA S 1615 §103 Final Rejection — Pending Nov 20, 2023
18562601 PHARMACEUTICAL COMPOSITIONS CONTAINING STABLE AMORPHOUS SOLID SOLUTIONS AND DISPERSIONS KAMM, JUDITH MARIE 1658 §103 Non-Final OA — Pending Nov 20, 2023
18290485 A PLATFORM FOR THE FAST, LABEL-FREE, AUTOMATED EVALUATION OF STERILITY AND BIOBURDEN SHI, TINGCHEN 1657 §103§112 Non-Final OA — Pending Nov 14, 2023
18558908 INHIBITORS OF SARS-COV-2 JACKSON, SHAWQUIA 1626 §102 Final Rejection — Pending Nov 03, 2023
18558995 SMALL MOLECULE ANTAGONISTS AND AGONISTS OF ARTHROPOD KININ RECEPTORS FOR PEST CONTROL BAUER, BRIANNA LEE 1623 §102§103§112DP Non-Final OA — Pending Nov 03, 2023
18288289 INTRACELLULAR TARGETED NANOCARRIERS: TOWARDS CONTROLLED DRUG DELIVERY FOR NONINVASIVE NEUROREGENERATION TREATMENT SAEED, ALI S 1616 §102§103§112 Final Rejection 19d overdue Pending Oct 25, 2023
18484667 METHODS AND COMPOSITIONS FOR ADAPTIVE IMMUNE MODULATION LEONARD, ARTHUR S 1631 §101§112DP Final Rejection 27d Pending Oct 11, 2023
18450884 Nuclear Reactor Thermal Management System WASIL, DANIEL D 3646 §103§112 Non-Final OA — Pending Aug 16, 2023
18358846 TECHNIQUES FOR PROVIDING SITUATIONAL AWARENESS BUKSA, CHRISTOPHER ALLEN 3658 §103 Non-Final OA — Pending Jul 25, 2023
18224207 SYSTEMS AND METHODS FOR PREPARATION OF HIGHLY REACTIVE ALKALI METAL DENDRITES FOR THE SYNTHESIS OF ORGANOLITHIUM REAGENTS BRADY, KRISTEN WEEKS 1692 §102§103§112 Non-Final OA 12d Pending Jul 20, 2023
18273293 SYSTEMS AND METHODS FOR EVALUATION OF STRUCTURE AND PROPERTY OF POLYNUCLEOTIDES FUELLING, MICHAEL 3992 §101 Non-Final OA — Pending Jul 20, 2023
18346632 IN-CORE PRINTED CIRCUIT HEAT EXCHANGER DAVIS, SHARON M 3646 §103 Final Rejection — Pending Jul 03, 2023
18344524 METHODS AND PLATFORM FOR SCREENING AND SELECTING METABOLITES AND THEIR RECEPTORS MUMMERT, STEPHANIE KANE 1681 §102 Non-Final OA — Pending Jun 29, 2023
18123171 OFFSHORE ANCHORING SYSTEMS AND ASSOCIATED METHODS BURGESS, MARC R 3615 §102§103 Final Rejection 15d overdue Pending Mar 17, 2023
18113472 SYSTEMS AND METHODS FOR OPTIMIZING THE MANAGEMENT OF WORKSITES AUSTIN, JAMIE H 3625 §101 Final Rejection 27d Pending Feb 23, 2023
18112279 SYSTEMS AND METHODS FOR FABRICATING PHYSIOLOGICALLY RELEVANT IN VITRO VESSELS MARTIN, PAUL C 1653 §103 Final Rejection — Pending Feb 21, 2023
18020771 MOBILE PERSONAL PROTECTIVE EQUIPMENT STATIONS TRAN, JULIE THI 3791 §103§112 Non-Final OA — Pending Feb 10, 2023
18019189 BONDING DISSIMILAR MATERIALS USING RADIO FREQUENCY WAVE CURING DAVIDSON IV, CULLEN LEE GARRETT 1767 §102§103§112 Non-Final OA 15d Pending Feb 01, 2023

View all 59 →

Managing The Texas A&M University System's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does The Texas A&M University System have?

The Texas A&M University System has 59 pending office actions as of October 2026, spread across 45 art units and 58 examiners.

Which USPTO examiner handles the most The Texas A&M University System applications?

Carib A Oquendo has the most, with 2 of The Texas A&M University System's pending office actions.

What technology area are The Texas A&M University System's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month